Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis

Phase 3

Recruiting

• Conditions: upus Nephritis patients; Lupus Nephritis patients; Renal and Urogenital - Kidney disease; Inflammatory and Immune System - Autoimmune diseases

• Registration Number: ACTRN12611000798965
• Lead Sponsor: Royal Brisbane

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-07-29
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Patients with clinically defined signs and symptoms of Lupus nephritis and on Mycphenolate Sodium for 2 weeks

Exclusion Criteria

1.Patients with a history of psychological illness or condition which interferes with their ability to understand or comply with the requirements of the study.
2.Patients unable to give consent.
3.Pregnant or nursing (lactating) women,

Study & Design

• Study Type: Interventional
• Study Design: Not specified